Trial intelligence / Profile preview

Beta-blockers to prevent decompensation in compensated cirrhosis with clinically significant portal hypertension

2009-010396-25Phase 4Completed

Sponsor
CÃ ndid Villanueva
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of propranolol and carvedilol in Cirrhosis and Portal Hypertension (PH) (2 arms), sponsored by CÃ ndid Villanueva. Started Mar 2009; status: completed.

02

Drugs

propranololcarvedilol
03

Conditions

CirrhosisPortal Hypertension (PH)

Beyond the preview

Go deeper on 2009-010396-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010396-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call